Senior Scientist
AstraZeneca, Maryland
Dr. Indira Prajapati is a formulation scientist within the BioPharmaceutical Development department at AstraZeneca, contributing her expertise to the late-stage formulation sciences group. Her research emphasizes on the impact of various formulation components on the stability of drug products. She specializes in utilizing machine learning and predictive modeling tools to gain mechanistic understanding of subvisible particle formation in monoclonal antibodies (mAbs) and innovative therapeutic modalities.
Dr. Prajapati completed her Bachelor's degree in Chemistry at Bethune-Cookman University, followed by a Ph.D. in Pharmaceutical Chemistry from the University of Kansas. Throughout her graduate studies, she focused on critical areas including photodegradation and metal catalysis involving proteins, peptides, and surfactants.
Disclosure information not submitted.
Predicting Subvisible Particle Formation of Monoclonal Antibodies
Wednesday, May 7, 2025
2:15 PM - 2:30 PM ET